Position in ZTS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$45,271
-$35,584 QoQ
Shares Held
630
-7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,143
of 1,408 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Wealth Enhancement Trust Services, Inc. holds $170,122 across 15 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
5,696 | $90,452 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
630 | $45,271 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
154 | $25,955 | |
| 4 | PRGO |
PERRIGO Co plc
|
164 | $1,703 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
197 | $1,560 | |
| 6 | EBS |
Emergent BioSolutions Inc.
|
145 | $1,215 | |
| 7 | ORGO |
Organogenesis Holdings Inc.
|
428 | $1,040 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
98 | $980 |
All Filings in ZTS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,271 | 630 | Shares | Defined | 2026-07-22 | |
| 2026-03-31 | $80,855 | 684 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $86,311 | 686 | Shares | Defined | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||